Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions - Wikidata - wikimedia - TriplyDB

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions

http://www.wikidata.org/entity/Q30432850

about

Consequences of repeated blood-brain barrier disruption in football players Extracranial sources of S100B do not affect serum levels Pathophysiological impact of cigarette smoke exposure on the cerebrovascular system with a focus on the blood-brain barrier: expanding the awareness of smoking toxicity in an underappreciated area Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products Blood biomarkers for brain injury: What are we measuring?Blood-brain barrier, bulk flow, and interstitial clearance in epilepsy Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics Serum S100B: a potential biomarker for suicidality in adolescents?GAD65 antibodies, chronic psychosis, and type 2 diabetes mellitus ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy.Serum S100B levels after meningioma surgery: A comparison of two laboratory assays.Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphological Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkers Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.Peripheral markers of brain damage and blood-brain barrier dysfunction Is peripheral immunity regulated by blood-brain barrier permeability changes?Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review.S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance High S100B levels in cerebrospinal fluid and peripheral blood of patients with acute basal ganglial hemorrhage are associated with poor outcome The S100B protein in biological fluids: more than a lifelong biomarker of brain distress.Blood-brain barrier integrity may be threatened by exercise in a warm environment.Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas.Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients.Biomarkers as outcome predictors in subarachnoid hemorrhage--a systematic review Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hits Early postoperative serum S100 beta levels predict ongoing brain damage after meningioma surgery: a prospective observational study Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury S100B blood levels and childhood trauma in adolescent inpatients S100β as a novel and accessible indicator for the presence of monocyte-driven encephalitis in AIDS Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor.To study the correlation of serum S-100 protein level with the severity of stroke and its prognostic implication A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children.Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury.Neuropsychological testing and biomarkers in the management of brain metastases The potential utility of blood-derived biochemical markers as indicators of early clinical trends following severe traumatic brain injury.S100B and S100B autoantibody as biomarkers for early detection of brain metastases in lung cancer.Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis.Serum S100B represents a new biomarker for mood disorders.S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage.

P2860

Q21133671-171E26A2-3750-43CA-948B-A6BC2063CA9F Q22241536-73DADF31-C2B6-401E-8597-4A2457C515C1 Q24627871-7B2CECF3-A7BF-4979-A911-528D1A4EE46C Q26777643-74D8E9BF-888B-4070-9CF9-6B68DFC58DAC Q28067275-FA38AA0D-7F1A-4DAB-8924-D487C6D75BD2 Q28086846-A9EFA774-70A1-41E0-91C7-F04FBAA101FB Q28477533-659E9C35-12E7-4B18-9CE3-78A78C80F66F Q28751578-74C6EEB3-ADE1-4ED2-B798-30677F3835E3 Q30430711-564BC58E-D73C-4188-804E-3CF622EE320C Q30485388-070CB3F5-CC9E-4DB7-8494-DE2A6C588546 Q30578055-4509BE22-329F-4729-8E6B-AB4042F8290E Q33370648-AF551FF3-5D10-42F9-9050-E346C79E299A Q33504619-278FCA5E-5CD7-4666-A81C-F8A4B201FDA9 Q33595790-54CCD04F-2298-4451-8D73-A92F0BB4590A Q33657728-1B06C1A9-CE02-4656-8D5A-167862B63A1A Q33789473-60F680CA-CBD4-49A8-9EB9-F02D2CB42D9B Q33838466-7B856940-177A-4297-BB6F-6C6840E9DF3D Q33863821-475C360D-4B14-4920-8540-A1B101E22BBE Q33984573-392F24D3-B1BE-4833-82FE-2C5DAB6A84F1 Q34031981-39CF26BD-0D5D-477E-A006-17197C17DBB0 Q34238722-3FE84273-40C7-4CCA-853E-B8717E866436 Q34384307-3DCAB2C2-37A8-4A22-9FB6-E858703DABD3 Q35067781-E1DD2D61-C71A-4367-85C8-6D75A8F18643 Q35109940-91C046C3-6278-489D-AA8B-0CB5A1899ED2 Q35136554-2A26BF4A-A94D-4C18-9DAC-6B3A7371F86A Q35164692-8B2BECB4-F8EA-4B94-AF67-86DBCE7DEB3A Q35544698-7EDFD04E-CCE9-40C3-A647-D13C93B9A171 Q35547437-FEB13F92-596A-4988-A8B9-B43A8A0AE842 Q35551126-E203E965-F130-45C5-9CFF-288E6A637677 Q35603172-448A55D8-1426-4969-91B1-1944A3DAAA80 Q35778571-5D920470-B8FA-44AD-8DA0-97B7DF060492 Q35785224-134EDB15-7B1C-44CD-AA80-667902719D18 Q35984262-DA0D4C17-41E5-4B03-A711-BEF18336AB70 Q36763899-BEF61E52-48EE-4336-BFDC-35D7D1CB1EBE Q36915247-0021F019-79E0-4650-83B6-0F232DE03CCE Q37154481-39B9040B-2D08-4C93-A8FC-893E2F7633E5 Q37227291-5F99365F-C8BC-4335-9401-F6750C9FA48B Q37250446-D840099A-361A-4463-B6C0-19AA5F43CCA3 Q37290664-B8AE9367-5360-4C87-9A31-196BDDE76313 Q37318243-6A9C7AED-74F1-4C98-A7F1-2BEEC3AA9071

P2860

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions

http://www.wikidata.org/entity/Q30432850

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions

@ast

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions

@en

type

label

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions

@ast

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions

@en

prefLabel

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions

@ast

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions

@en

P1433

Q30432850-6571BABB-D444-4776-BD29-C2FE7E636468

P1476

Q30432850-74B372E3-C3C2-4F7D-A2C6-3A065A99B94E

P2093

Q30432850-0CB50B41-75AF-4E04-B1EA-AAF5E06B2ACE

Q30432850-0D6DFA77-5022-42D4-832E-82C576226436

Q30432850-1C2CF306-82A8-4370-8F6E-29C2E8DCAF65

Q30432850-3A7AE040-C4D2-4754-A946-953AF088CA87

Q30432850-6AF9EEB0-5148-4AAC-BF39-24A37C6316BA

Q30432850-947934B6-829F-4AF5-8338-411A4B1C7269

Q30432850-AA48EBA7-9AC6-4D19-8622-18A7A9F34B58

Q30432850-CC339C91-927E-4E34-A19C-4CCF271472A7

Q30432850-F8096736-F66D-403C-B8EE-1C47BE24241B

P2860

Q30432850-0D701BA1-F3C1-47D7-8CBC-ABB6CEF58C53

Q30432850-1742A54D-14E5-4B8F-BD4E-822249C13A4D

Q30432850-1946D621-D321-43D2-920F-FE35B9983006

Q30432850-20312E25-F756-4C74-B153-E9371BF7F209

Q30432850-260820AD-DF16-47EE-8FA2-EEE71AC643A2

Q30432850-2CBC59FC-A528-4969-8C23-022E200263DC

Q30432850-40895B46-8EC8-4E95-8069-315D91CC5191

Q30432850-4908465C-78A3-4361-B0E5-B5055482EBE3

Q30432850-4DADBA07-310A-4727-B53F-027C7887212E

Q30432850-5E469447-3145-4200-A872-45FD4A51C04C

P304

Q30432850-A5FF3AC2-1069-49CA-8339-08AB55A98A7F

P31

Q30432850-453520C9-0BF6-4DA6-8E98-4FB59F6F5C73

P356

Q30432850-4DF0260C-98D2-4CAC-A624-67F200F16678

P407

Q30432850-F9854F83-E33E-48A1-A1B4-7BFC7F7E3A65

P433

Q30432850-C3F5B1F1-D97E-4CC1-92AC-4CE051DFDD2C

P478

Q30432850-C8B452B1-D788-4839-8088-4E89275F5E4B

P50

Q30432850-9D531270-ABB9-4518-A1F2-DC73EEB20B83

Q30432850-A0B26871-5284-45B1-9571-534626BA708A

Q30432850-CCDCD807-244D-44F3-AD17-22A6440C36C4

P577

Q30432850-8FE46E28-7AB8-42F6-BB1E-B064F1F403F0

P5875

Q30432850-9E92115F-2956-452D-ABE0-A00281B1FB11

P698

Q30432850-978BC0C7-9807-453E-B171-8327AA3D872C

P921

Q30432850-CB1E4B08-9699-45CD-B4C7-057BB1132DDC

P932

Q30432850-3CC9B8DE-6E1C-4C48-8CEF-D6911E71FC55

P356

P1433

P1476

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions

@en

P2093

Andrew A Kanner

http://www.w3.org/2001/XMLSchema#string

Barbara Aumayr

http://www.w3.org/2001/XMLSchema#string

Glen H J Stevens

http://www.w3.org/2001/XMLSchema#string

Marc R Mayberg

http://www.w3.org/2001/XMLSchema#string

Michael A Vogelbaum

http://www.w3.org/2001/XMLSchema#string

Michael T Koltz

http://www.w3.org/2001/XMLSchema#string

Thomas Masaryk

http://www.w3.org/2001/XMLSchema#string

Vincent Fazio

http://www.w3.org/2001/XMLSchema#string

Vitaly Siomin

http://www.w3.org/2001/XMLSchema#string

P2860

The S100 family of EF-hand calcium-binding proteins: functions and pathology

Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption.

Contrast media and the brain. The basis of CT and MR imaging enhancement.

Peripheral markers of brain damage and blood-brain barrier dysfunction

Inflammatory mediators and modulation of blood-brain barrier permeability.

Serological markers for melanoma.

Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.

MR and cognitive testing of patients undergoing osmotic blood-brain barrier disruption with intraarterial chemotherapy.

Blood-brain barrier: phenomenon of increasing importance to the imaging clinician.

Significance of serum S100 release after coronary artery bypass grafting.

P304

2806-2813

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.11409

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Gene H. Barnett

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7144355

http://www.w3.org/2001/XMLSchema#string

P698

12767094

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

P932

4135471

http://www.w3.org/2001/XMLSchema#string